<DOC>
	<DOC>NCT01241487</DOC>
	<brief_summary>This study is to assess the efficacy of the fixed combination of Valsartan and Amlodipine in hypertensive patients uncontrolled by monotherapy.</brief_summary>
	<brief_title>A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine, Valsartan Drug Combination</mesh_term>
	<criteria>Patient uncontrolled by monotherapy for at least 8 weeks, having B.P.&gt;/= 140/90 mmHg in non diabetics or &gt;/= 130/80 mmHg in diabetics Patient having B.P.&gt;= 180/110 mmHg in non diabetics or &gt;= 160/100 mmHg in diabetics Type 1 Diabetes or uncontrolled type 2 Diabetes. PCI in last 12 months. Concomitant unstable angina. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension, Valsartan/Amlodipine,</keyword>
</DOC>